Abstract: 26 HIGH-DOSE ATORVASTATIN PROVIDES SUSTAINED BENEFIT IN REDUCING RISK OF CV DISEASE AMONG STABLE CHD PATIENTS ≥65 YEARS
Wenger, N, LaRosa, J, Shepherd, JVolume:
10
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/s1567-5688(09)70090-x
Date:
June, 2009
File:
PDF, 146 KB
english, 2009